DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Galiximab
Galiximab
Fig. L COMPOSITIONS and METHODS to INHIBIT STEM CELL and PROGENITOR CELL BINDING to LYMPHOID TISSUE and for REGENERATING GERMINAL CENTERS in LYMPHATIC TISSUES
Modifications to the Harmonized Tariff Schedule of the United States To
The Two Tontti Tudiul Lui Hi Ha Unit
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
(12) United States Patent (10) Patent No.: US 8,883,146 B2 Fraunhofer Et Al
Monoclonal Antibody Therapy for Classical Hodgkin Lymphoma
Newer Monoclonal Antibodies for Hematological Malignancies
Molecular Targeted Therapies for Indolent Lymphomas: Where Are
Update on Galiximab: Anti-CD80 Monoclonal Antibody
Galiximab (Anti-CD80)-Induced Growth Inhibition and Prolongation of Survival in Vivo of B-NHL Tumor Xenografts and Potentiation by the Combination with Fludarabine
INN Working Document 05.179 Update 2011
Transforming Discovery Into Care 2007 ANNUAL REPORT Highlights
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Biosimilar Antibodies & ELISA Kits
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
Novel Antibodies in the Treatment of Non-Hodgkin's Lymphoma
Top View
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Immunotherapy of Hematologic Malignancies
Wo 2010/095940 A2
Full Text (PDF)
The Current State and the Issues of Antibody Drugs
Research-Grade Biosimilars
Single-Chain Variable Fragment
Immunology at Biogen Idec
Highlights from the 10Th International Conference on Malignant Lymphoma: a Review of Selected Presentations
Activated B-Cell
Hematology Drugs in the Pipeline
I Nuovi Anticorpi Anti-Linfoma
The Era of Chemotherapy-Free Treatment for Follicular Lymphoma
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
(INN) for Biological and Biotechnological Substances
Biosimilar Monoclonalantibodies
Thalidomide - Wikipedia, the Free Encyclopedia
Assessment of the Evolution of Cancer Treatment Therapies
Advances in LLM
Biogen Idec Inc. (Exact Name of Registrant As Specified in Its Charter)
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Recombinant Antibody Catalog
Anti-CD80 [IDEC-114 (Galiximab)] Standard Size Ab00736- 23.0
Lymphomas and Lymphocytes